ArticleToxins2022

Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study.

Ilenia Corbelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.